Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Erlotinib Impurity 14 | HCID 9868438 | — |
| Solvent | 2-Methoxyethanol | HCID 8019 | — |
| Product | Erlotinib Hydrochloride | HCID 176871 | — |
Reaction Steps
4-[3-[[6,7-Bis(2-methoxyethoxy]-4-quinazolinyl]amino]phenyl]-2-methyl-3-butyn-2-ol, prepared above (5.0 g, 11 mmol), anhydrous solid sodium hydroxide (44 mg, 11 mmol) and 2-methoxyethanol (50 mL) were stirred together and heated at reflux for 47 hours. The reaction mixture was cooled to 20-25° C. and concentrated hydrochloric acid (1.1 mL) was added. The resultant mixture was granulated at 20-25° C. for 1 hour to establish crystallization. The title product crystals were isolated by filtration, washed with 2-methoxyethanol (10 mL) and dried under vacuum at 45-50° C. to remove 2-methoxyethanol. Yield (3.73 g, 78%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06476040B1 |
|---|
| Source dataset | uspto-grants-2002_11 |
|---|
| ORD ID | ord-19734306a62c48b89d74c547f8cd2533 |
|---|
| Source note | uspto-grants-2002_11 |
|---|